Cargando…
Clopidogrel treatment may associate with worsening of endothelial function and development of new digital ulcers in patients with systemic sclerosis: results from an open label, proof of concept study
BACKGROUND: Activated platelets release serotonin that binds 5-HT(2B) receptor on fibroblasts leading to fibroblast activation. Clopidogrel, an inhibitor of ADP-dependent platelet activation prevents fibrosis in animal models of systemic sclerosis (SSc). We aimed at assessing whether i) ADP-dependen...
Autores principales: | Ntelis, Konstantinos, Gkizas, Vasileios, Filippopoulou, Alexandra, Davlouros, Periclis, Alexopoulos, Dimitrios, Andonopoulos, Andrew P., Daoussis, Dimitrios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869184/ https://www.ncbi.nlm.nih.gov/pubmed/27188755 http://dx.doi.org/10.1186/s12891-016-1072-1 |
Ejemplares similares
-
Should we be Afraid of Immune Check Point Inhibitors in Cancer Patients with Pre-Existing Rheumatic Diseases? Immunotherapy in Pre-Existing Rheumatic Diseases
por: Klavdianou, Kalliopi, et al.
Publicado: (2021) -
A Case Report of Favourable Response of Polymyositis to Methotrexate Monotherapy
por: Daoussis, Dimitrios, et al.
Publicado: (2021) -
B cell depletion therapy upregulates Dkk-1 skin expression in patients with systemic sclerosis: association with enhanced resolution of skin fibrosis
por: Daoussis, Dimitrios, et al.
Publicado: (2016) -
Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study
por: Daoussis, Dimitrios, et al.
Publicado: (2010) -
Rheumatic Manifestations in Patients Treated with Immune Checkpoint Inhibitors
por: Melissaropoulos, Konstantinos, et al.
Publicado: (2020)